BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18217146)

  • 1. Factor XIa and tissue factor activity in patients with coronary artery disease.
    Butenas S; Undas A; Gissel MT; Szuldrzynski K; Zmudka K; Mann KG
    Thromb Haemost; 2008 Jan; 99(1):142-9. PubMed ID: 18217146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Orbe J; Zudaire M; Serrano R; Coma-Canella I; Martínez de Sizarrondo S; Rodríguez JA; Páramo JA
    Thromb Haemost; 2008 Feb; 99(2):382-7. PubMed ID: 18278189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients.
    Ząbczyk M; Butenas S; Plicner D; Fijorek K; Sadowski J; Undas A
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):189-94. PubMed ID: 22343680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes.
    Emekli-Alturfan E; Basar I; Alturfan AA; Ayan F; Koldas L; Balci H; Emekli N
    Pathophysiol Haemost Thromb; 2007; 36(6):290-7. PubMed ID: 20224254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease.
    Stellbaum C; Willich T; Boltzen U; Ayral Y; Szotowski B; Piorkowski M; Schultheiss HP; Rauch U
    Eur J Haematol; 2007 Apr; 78(4):347-52. PubMed ID: 17331131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
    Empana JP; Canoui-Poitrine F; Luc G; Juhan-Vague I; Morange P; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Ducimetiere P;
    Eur Heart J; 2008 Aug; 29(16):1966-74. PubMed ID: 18621771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between inflammation and thrombosis in acute coronary syndrome.
    Lytvyn OI; Kopitsa MP; Petyunina OV
    Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
    Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
    Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
    Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.
    Martins TB; Anderson JL; Muhlestein JB; Horne BD; Carlquist JF; Roberts WL; Carlquist JF
    Am J Clin Pathol; 2006 Jun; 125(6):906-13. PubMed ID: 16690490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin-II levels in acute coronary syndromes.
    Joyal D; Huynh T; Aiyar N; Guida B; Douglas S; Giaid A
    Int J Cardiol; 2006 Mar; 108(1):31-5. PubMed ID: 16516696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.